Dopamine receptor D4

The dopamine receptor D4 (DRD4) is a G protein-coupled receptor that is encoded by the DRD4 gene in humans. It is one of the five types of dopamine receptors, which are responsible for the physiological effects of the neurotransmitter dopamine. The D4 receptor is of particular interest due to its role in the modulation of cognition, emotion, and behavior.
Structure[edit]
The D4 receptor is a member of the D2-like receptor family, which also includes the dopamine receptor D2 and dopamine receptor D3. These receptors are characterized by their ability to inhibit the enzyme adenylyl cyclase through the activation of Gi/o proteins. The D4 receptor has a high degree of polymorphism, particularly in the third intracellular loop, which may influence its function and expression.
Function[edit]
D4 receptors are primarily found in the frontal cortex, amygdala, hypothalamus, and hippocampus. They play a crucial role in modulating synaptic transmission and are involved in the regulation of mood, attention, and reward. The D4 receptor has been implicated in various neuropsychiatric disorders, including schizophrenia, bipolar disorder, and attention deficit hyperactivity disorder (ADHD).
Ligands[edit]
D4 receptors can be targeted by various ligands, which can act as either agonists or antagonists. Agonists such as apomorphine and dopamine itself activate the receptor, while antagonists like clozapine and haloperidol inhibit its activity. The development of selective D4 receptor ligands is an area of active research, with potential therapeutic applications in treating psychiatric disorders.
Clinical Significance[edit]
The D4 receptor has been studied extensively in the context of pharmacogenetics, as variations in the DRD4 gene have been associated with differences in drug response and susceptibility to certain disorders. For example, the 7-repeat allele of the DRD4 gene has been linked to an increased risk of ADHD and novelty seeking behavior.
Related Pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian